REFERENCES
- Andén, N.-E., Butcher, S. G., Corrodi, H., Fuxe, K. & Ungerstedt, U. 1970. Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Eur J Pharmacol 11, 303.
- Benson, G. S., Raezer, D. M., Anderson, J. R., Saunders, C. D. & Corriere, J. N. 1976. Effect of levodopa on urinary bladder. Urology 7, 24.
- Bertler, A., Falck, B., Owman, C. H. & Rosengrenn, E. 1966. The localization of monoaminergic blood-brain barrier mechanisms. Pharmacol Rev 18, 369.
- Bors, E. & Comarr, A. E. 1971. Neuroanatomy and neurophysiology. In: Neurological urology, chap. 3, pp. 61–128. S. Karger, Basel.
- Dahlström, A. & Fuxe, K. 1965. Evidence for the existence of monoamine neurons in the central nervous system. Acta Physiol Scand 64, Suppl. 247, 1.
- Elmér, M. 1974. Action of drugs on the innervated and denervated urinary bladder of the rat. Acta Physiol Scand 91, 289.
- Henning, M. 1969. Interaction of DOPA decarboxylase inhibitors with effect of α-metyldopa on blood pressure and tissue monoamines in rats. Acta Pharmacol Toxicol 27, 135.
- Henning, M. & Rubenson, A. 1970. Central hypotensive effect of L-3, 4-dihydroxyphenylalanine in the rat. J Pharm Pharmacol 22, 553.
- Kuru, M. 1965. Nervous control of micturition. Physiol Rev 45, 425.
- Nergårdh, A. 1975. Autonomic receptor functions in the lower urinary tract: A survey of recent experimental results. J Urol 113, 180.
- Schmitt, H., Schmitt, Mme H., Boissier, J. R., Giudicelli, J. F. & Fichelle, J. 1968. Cardiovascular effects of 1-(2, 6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155). Eur J Pharmacol 2, 340.